Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats

Author： Gao Wei   Bihorel Sébastien   DuBois Debra   Almon Richard   Jusko William  

Publisher： Springer Publishing Company

ISSN： 1567-567X

Source： Journal of Pharmacokinetics and Pharmacodynamics, Vol.38, Iss.1, 2011-02, pp. : 143-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Soybean Oil on Glycaemic Control in Goto-Kakizaki Rats,an Animal Model of Type 2 Diabetes

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 293-297

Bentham Science Publishers

Access to resources Recommend Favorite

Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats

By Ohta T.   Miyajima K.   Komuro G.   Furukawa N.   Yonemori F.  

European Journal of Pharmacology, Vol. 476, Iss. 1, 2003-08 ,pp. : 159-166

Elsevier

Access to resources Recommend Favorite

Irbesartan reduces progression of renal disease in type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic aspects of losartan treatment to delay progression of renal disease in patients with Type 2 diabetes

By Postma Maarten J   Kruidhof Hanneke   Berg Lolkje TW de Jong-van den   Zeeuw Dick de  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1543-1550

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone slows progression of CIMT in type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite